Orion Corporation: Managers’ transactions – Kari Jussi Aho
ORION CORPORATION
MANAGERS’ TRANSACTIONS
9 MARCH 2023 at 11.30 EET
Orion Corporation: Managers’ transactions – Kari Jussi Aho
Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.
Orion Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Kari Jussi Aho
Position: Member of the Board/Deputy member
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 26870/7/10
____________________________________________
Transaction date: 2023-03-07
Venue: CEUD
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 2 Unit price: 44.375 EUR
(2): Volume: 75 Unit price: 44.4 EUR
Aggregated transactions (2):
Volume: 77 Volume weighted average price: 44.39935 EUR
____________________________________________
Transaction date: 2023-03-07
Venue: DHEL
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 6 Unit price: 44.35 EUR
Aggregated transactions (1):
Volume: 6 Volume weighted average price: 44.35 EUR
____________________________________________
Transaction date: 2023-03-07
Venue: TQEM
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 2 Unit price: 44.375 EUR
Aggregated transactions (1):
Volume: 2 Volume weighted average price: 44.375 EUR
____________________________________________
Transaction date: 2023-03-07
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 1 Unit price: 44.35 EUR
(2): Volume: 2 Unit price: 44.35 EUR
(3): Volume: 6 Unit price: 44.35 EUR
(4): Volume: 4 Unit price: 44.35 EUR
(5): Volume: 1 Unit price: 44.4 EUR
(6): Volume: 46 Unit price: 44.4 EUR
(7): Volume: 2 Unit price: 44.4 EUR
Aggregated transactions (7):
Volume: 62 Volume weighted average price: 44.38952 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: BEUP
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 16 Unit price: 44.625 EUR
(2): Volume: 16 Unit price: 44.65 EUR
(3): Volume: 34 Unit price: 44.65 EUR
Aggregated transactions (3):
Volume: 66 Volume weighted average price: 44.64394 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: CEUX
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 41 Unit price: 44.8 EUR
(2): Volume: 40 Unit price: 44.55 EUR
(3): Volume: 42 Unit price: 44.55 EUR
Aggregated transactions (3):
Volume: 123 Volume weighted average price: 44.63333 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: DHEL
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 8 Unit price: 44.375 EUR
(2): Volume: 75 Unit price: 44.275 EUR
(3): Volume: 3 Unit price: 44.275 EUR
(4): Volume: 35 Unit price: 44.275 EUR
Aggregated transactions (4):
Volume: 121 Volume weighted average price: 44.28161 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: TQEM
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 63 Unit price: 44.65 EUR
(2): Volume: 234 Unit price: 44.475 EUR
(3): Volume: 69 Unit price: 44.35 EUR
(4): Volume: 191 Unit price: 44.35 EUR
Aggregated transactions (4):
Volume: 557 Volume weighted average price: 44.43645 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: TQEX
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 41 Unit price: 44.55 EUR
Aggregated transactions (1):
Volume: 41 Volume weighted average price: 44.55 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 32 Unit price: 44.8 EUR
(2): Volume: 144 Unit price: 44.7 EUR
(3): Volume: 1 Unit price: 44.65 EUR
(4): Volume: 3 Unit price: 44.65 EUR
(5): Volume: 150 Unit price: 44.65 EUR
(6): Volume: 299 Unit price: 44.55 EUR
(7): Volume: 35 Unit price: 44.35 EUR
(8): Volume: 55 Unit price: 44.35 EUR
(9): Volume: 65 Unit price: 44.45 EUR
(10): Volume: 10 Unit price: 44.45 EUR
(11): Volume: 29 Unit price: 44.45 EUR
(12): Volume: 150 Unit price: 44.45 EUR
(13): Volume: 9 Unit price: 44.45 EUR
(14): Volume: 150 Unit price: 44.45 EUR
(15): Volume: 11 Unit price: 44.4 EUR
(16): Volume: 150 Unit price: 44.4 EUR
(17): Volume: 13 Unit price: 44.4 EUR
(18): Volume: 150 Unit price: 44.4 EUR
(19): Volume: 17 Unit price: 44.35 EUR
(20): Volume: 150 Unit price: 44.35 EUR
(21): Volume: 150 Unit price: 44.35 EUR
(22): Volume: 150 Unit price: 44.35 EUR
(23): Volume: 9 Unit price: 44.35 EUR
(24): Volume: 18 Unit price: 44.35 EUR
(25): Volume: 150 Unit price: 44.35 EUR
(26): Volume: 9 Unit price: 44.35 EUR
(27): Volume: 150 Unit price: 44.35 EUR
(28): Volume: 2 Unit price: 44.35 EUR
(29): Volume: 18 Unit price: 44.3 EUR
(30): Volume: 8 Unit price: 44.3 EUR
(31): Volume: 11 Unit price: 44.3 EUR
(32): Volume: 1 Unit price: 44.3 EUR
(33): Volume: 2 Unit price: 44.3 EUR
(34): Volume: 5 Unit price: 44.3 EUR
(35): Volume: 12 Unit price: 44.3 EUR
(36): Volume: 99 Unit price: 44.3 EUR
(37): Volume: 19 Unit price: 44.3 EUR
(38): Volume: 9 Unit price: 44.3 EUR
Aggregated transactions (38):
Volume: 2445 Volume weighted average price: 44.43961 EUR
Orion Corporation
| Liisa Hurme President and CEO | Olli Huotari SVP, Corporate Functions |
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Financière de Tubize - Dividend approval27.4.2024 08:00:00 CEST | Press release
Dividend confirmation Regulated information - 26 april 2024 The general shareholders meeting of 26 April 2024 has approved the annual accounts as at 31 December 2023, including the distribution of a gross dividend of € 0.97 per share. The dividend will be payable as from 3 May 2024 onwards at the offices, seats and branches of BNP Paribas Fortis, in exchange of coupon n° 19. Ex-coupon 30 April 2024 Record date 2 May 2024 Payment date 3 May 2024
EPH European Property Holdings PLC announces 2023 Year-End Result26.4.2024 23:55:00 CEST | Press release
26 April 2024, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR BUSINESS HIGHLIGHTS 2023 Despite the challenging market environment, EPH European Property Holdings PLC (“EPH” or the “Company”) maintained operational stability in 2023. This success can be attributed to its established portfolio of high-quality properties in prime locations in Europe, and professional asset management. As a result, EPH once again achieved almost full occupancy throughout its European portfolio, and exceeded own expectations by increasing net rental income by 26 percent compared to the previous year.As of 31 December 2023, EPH’s real estate portfolio consisted of eight core assets (and one parking garage) in outstanding locations in Germany and Vienna, all of which meet high sustainability standards. Seven out of eight office and hotel buildings have already been awarded certificates in DGNB Platinum, DGNB Gold, or LEED Gold.A milestone in the operating business was the completion of the LASS
FRO – Filing of Annual Report26.4.2024 22:36:43 CEST | Press release
Frontline plc (the “Company”) announces the filing of its annual report for the year ended December 31, 2023. The annual report can be downloaded from the Company’s website www.frontlineplc.cy or from the link below. Additionally, shareholders can request a hard copy of our complete audited financial statements free of charge by writing to us at: John Kennedy 8 Iris Building, 7th floor, Flat/Office 740B, 3106, Limassol, Cyprus. or sending an e-mail to ir@frontmgt.no April 26, 2024 Frontline plc Limassol, Cyprus. Questions should be directed to: Lars H. Barstad: Chief Executive Officer, Frontline Management AS +47 23 11 40 00 Inger M. Klemp: Chief Financial Officer, Frontline Management AS +47 23 11 40 00 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Attachments 5493004BCIKYU1YL3H63-2023-12-31-enAnnual Report 2023
Kallelse till årsstämma 2024 i Fingerprint Cards AB (publ)26.4.2024 22:16:32 CEST | Pressemelding
Aktieägarna i Fingerprint Cards AB (publ), org. nr. 556154-2381 (”Bolaget” eller ”Fingerprint”), kallas härmed till årsstämma klockan 15.00 tisdagen den 28 maj 2024 på GT30 (mötesrum ”Bond”), Grev Turegatan 30 i Stockholm. Styrelsen har, i enlighet med Bolagets bolagsordning, beslutat att aktieägarna före årsstämman ska ha möjlighet att utöva sin rösträtt genom poströstning. Aktieägare kan därmed välja att utöva sin rösträtt vid stämman personligen, genom ombud eller genom poströstning. A. Rätt att delta på stämman Aktieägare som önskar delta vid årsstämman ska: vara införd i den av Euroclear Sweden AB förda aktieboken måndagen den 20 maj 2024, och anmäla sin avsikt att delta vid stämman till Bolaget i enlighet med anvisningarna under avsnitt ”B. Anmälan för deltagande personligen eller genom ombud” senast onsdagen den 22 maj 2024, eller avge en poströst i enlighet med anvisningarna under rubriken ”C.Anvisningar för poströstning” senast onsdagen den 22 maj 2024. För att ha rätt att del
Notice to attend the 2024 Annual General Meeting of Fingerprint Cards AB (publ)26.4.2024 22:16:32 CEST | Press release
The shareholders of Fingerprint Cards AB (publ), Corp. Reg. No. 556154-2381 (hereinafter referred to as the “Company” or “Fingerprint”)), are hereby invited to attend the Annual General Meeting (“AGM” or the “Meeting”) to be held at 3:00 p.m. on Tuesday, May 28, 2024, at GT30 (meeting room “Bond”), Grev Turegatan 30 in Stockholm. The Board of Directors has decided, pursuant to the Company’s articles of association, that shareholders shall also have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the Meeting by attending in person, through a proxy or by postal voting. A. Right to participate in the Meeting In order to participate in the Meeting, a shareholder shall: be registered in the register of shareholders maintained by Euroclear Sweden AB as of Monday, May 20, 2024, and give notice of attendance at the Meeting to the Company in accordance with the instructions set out in the section “B. Notice of atte